Health Care: Drugs

Tekmira Pharmaceuticals Corp (TKMR: NASDAQ)

$12.92 0.11 | 0.86%
08/01/14 - 11:11 AM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -14.06M 29.95M -9.73M -12.41M
Operating Gains/Losses 0.00 0.00 58.67K 7.18K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 857.97K 133.15K 2.46M -2.39M
(Increase) Decrease in Inventories 0.00 0.00 147.63K -150.71K
(Increase) Decrease In Other Current Assets 230.60K 0.00 0.00 0.00
(Decrease) Increase In Payables 130.00K -197.28K -2.13M 498.02K
(Decrease) Increase In Other Current Liabilities 0.00 -2.19M 619.11K 2.16M
(Increase) Decrease In Other Working Capital 1.86M -294.65K 127.16K -557.17K
Other Non-Cash Items 4.42M 4.90M 86.54K 650.52K
Net Cash From Continuing Operations -6.74M 33.27M -7.52M -11.25M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -6.74M 33.27M -7.52M -11.25M
Sale of Property, Plant & Equipment 0.00 2.50K 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -725.10K -14.90K -58.45K -830.82K
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -725.10K -12.40K -58.45K -830.82K
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 32.72M 3.93M 4.46M 34.91K
Repayment of Long-Term Debt 0.00 0.00 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 635.16K 0.00 0.00
Net Cash From Financing Activities 32.72M 4.57M 4.46M 34.91K
Effect of Exchange Rate Changes -3.56M -29.42K 19.68K -7.18K
Net Change in Cash & Cash Equivalents 21.69M 37.80M -3.10M -12.05M
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter